Long-acting cabotegravir plus rilpivirine (Cabenuva) achieved superior viral suppression vs daily oral antiretroviral therapy at 6months in treatment-experienced people with HIV and detectable viremia in the phase 3b CROWN trial.
|Videos|September 16, 2017
Latest Results of the Population-Based HIV Impact Assessment Project
Author(s)Contagion
Jessica Justman, MD, reveals the latest results of the Population-based HIV Impact Assessment Project (2017).
Advertisement
Jessica Justman, MD, senior technical director, ICAP, Mailman School of Public Health & associate professor of medicine in epidemiology, Columbia University reveals the latest results of the Population-based HIV Impact Assessment Project (2017). Dr. Justman shares that she does not believe that a HIV vaccine is necessarily needed to achieve to 90-90-90 targets, as we these goals have almost been reached in certain countries. Dr. Justman also calls to attention that the biggest challenges have to do with adolescents and young adults.
Advertisement
Related to this article
Lori Handy, MD, provides guidance in these areas, including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.
A 39-year-old unvaccinated Franklin County woman has died after a recent measles diagnosis. Nationally, numbers continue to increase and the US has passed 4,000 cases.
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
Pritelivir (Hovilpri) healed all lesions by day 28 in 63% of immunocompromised adults with refractory HSV versus 34% with investigator's choice in the phase 3 PRIOH-1 trial.
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.
UTI guidelines are moving away from complicated or uncomplicated infections to localized or systemic classification terminologies. Guidelines author Zachary Nelson, PharmD, MPH, BCIDP, provides further insights on the changes including applying antibiograms, potential costs, and whether clinicians will embrace these new classifications.
Demonstrating a diagnostic test works is no longer enough. Clinicians and laboratories also need evidence on how to adopt it in everyday practice. Andrea Prinzi, PhD, MPH, SM(ASCP), explains how implementation science can help infectious disease and clinical microbiology teams turn evidence into routine care.
Advertisement
Advertisement
Trending on Contagion Live
1
Ebola Update: DRC Outbreak Passes 8,700 Cases and 4,200 Deaths
2
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
3
Pennsylvania Coroner Reports Sixth Measles-Related Death
4
Measles Update: October 9, 2026
5